SCHEMBL6984797

SCHEMBL6984797

CCOC(=O)C1C=Nc2c(c(Cl)cc3cccnc23)C1=O

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 2/20 0.38
ALOX15 P16050 1/20 0.38
ALDH1A1 P00352 5/20 0.38
KDM4E B2RXH2 5/20 0.37
HTT P42858 3/20 0.37
TP53 P04637 2/20 0.37
HPGD P15428 2/20 0.37
HSD17B10 Q99714 1/20 0.37
CYP2C19 P33261 1/20 0.36
L3MBTL1 Q9Y468 2/20 0.35
CCR1 P32246 1/20 0.35
CCR8 P51685 1/20 0.35
MAPT P10636 4/20 0.35
KMT2A Q03164 4/20 0.35
NPSR1 Q6W5P4 4/20 0.35
MEN1 O00255 3/20 0.35
RAB9A P51151 2/20 0.35
NPC1 O15118 1/20 0.35
MPI P34949 1/20 0.35
ALOX12 P18054 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6985519 0.87 RELA (0.38) MAPK1ALOX15ALDH1A1KDM4EHTT
SCHEMBL6975182 0.83 L3MBTL1 (0.40) ALDH1A1L3MBTL1CCR1CCR8MAPT
SCHEMBL6985195 0.81 ALDH1A1 (0.42) MAPK1ALOX15ALDH1A1KDM4EHTT
SCHEMBL6987201 0.74 CCR1 (0.40) ALDH1A1KDM4ETP53L3MBTL1CCR1
SCHEMBL8521522 0.74 ALOX15 (0.40) MAPK1ALOX15ALDH1A1KDM4EHTT
SCHEMBL6981252 0.73 L3MBTL1 (0.38) MAPK1ALOX15ALDH1A1KDM4EHTT
SCHEMBL6985003 0.72 CCR1 (0.40) ALDH1A1L3MBTL1CCR1CCR8NPSR1
SCHEMBL965521 0.72 SLC40A1 (0.40) MAPK1ALDH1A1KDM4EHTTTP53
SCHEMBL967454 0.71 L3MBTL1 (0.39) ALDH1A1KDM4EHTTL3MBTL1MAPT
SCHEMBL28560072 0.70 KDM4E (0.40) MAPK1ALDH1A1KDM4ETP53HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1027351-B1 PHENANTHROLINE DERIVATIVES FIBROGEN INC (US) 2003-12-03 EP claimed
EP-1027351-B1 PHENANTHROLINE DERIVATIVES FIBROGEN INC (US) 2003-12-03 EP disclosed
US-20010001101-A1 Phenanthroline derivatives ZENECA LIMITED 2001-05-10 US disclosed
US-6200974-B1 FOR PRODUCING AN ANTI-FIBROPROLIFERATIVE EFFECT ZENECA LIMITED (GB) 2001-03-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010001101-A1 Phenanthroline derivatives H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, COL1A1, COL2A1 MAPK1 2230/4885ALOX15 2467/4885ALDH1A1 425/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.